for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Veracyte Inc

VCYT.OQ

Latest Trade

24.67USD

Change

-0.65(-2.57%)

Volume

156,477

Today's Range

24.06

 - 

25.30

52 Week Range

9.23

 - 

31.16

As of on the NASDAQ ∙ Minimum 15 minute delay

Latest Developments

Veracyte Q2 Loss Per Share $0.05

July 30 (Reuters) - Veracyte Inc <VCYT.O>::VERACYTE ANNOUNCES SECOND QUARTER 2019 FINANCIAL RESULTS.Q2 LOSS PER SHARE $0.05.Q2 EARNINGS PER SHARE ESTIMATE $-0.10 -- REFINITIV IBES DATA.SEES FY 2019 REVENUE $119 MILLION TO $122 MILLION.Q2 REVENUE $30.1 MILLION VERSUS REFINITIV IBES ESTIMATE OF $28.8 MILLION.COMPANY RAISES 2019 FULL-YEAR REVENUE GUIDANCE.FY2019 REVENUE VIEW $119.3 MILLION -- REFINITIV IBES DATA.

Veracyte Appoints Keith Kennedy To Serve As Chief Operating Officer

June 28 (Reuters) - Veracyte Inc <VCYT.O>::VERACYTE INC - APPOINTED KEITH KENNEDY TO ALSO SERVE AS COMPANY'S CHIEF OPERATING OFFICER, EFFECTIVE JULY 1, 2019..

Veracyte Announces Pricing Of Public Offering Of 5,500,000 Shares Of Common Stock

May 2 (Reuters) - Veracyte Inc <VCYT.O>::VERACYTE ANNOUNCES PRICING OF PUBLIC OFFERING OF 5,500,000 SHARES OF COMMON STOCK.PRICING OF UNDERWRITTEN PUBLIC OFFERING OF 5.5 MILLION SHARES OF ITS COMMON STOCK AT A PUBLIC OFFERING PRICE OF $23.25 PER SHARE.

Veracyte Inc Files For Potential Mixed Shelf Offering

May 1 (Reuters) - Veracyte Inc <VCYT.O>::VERACYTE INC FILES FOR POTENTIAL MIXED SHELF OFFERING; SIZE NOT DISCLOSED - SEC FILING.

Veracyte Announces Proposed Public Offering Of Common Stock

May 1 (Reuters) - Veracyte Inc <VCYT.O>::VERACYTE ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK.SAYS OFFERING 5.00 MILLION COMMON SHARES.INTENDS TO USE NET PROCEEDS FROM OFFERING FOR WORKING CAPITAL.

Veracyte Q1 Loss Per Share $0.05

April 30 (Reuters) - Veracyte Inc <VCYT.O>::VERACYTE ANNOUNCES FIRST QUARTER 2019 FINANCIAL RESULTS.Q1 LOSS PER SHARE $0.05.Q1 REVENUE $29.5 MILLION VERSUS REFINITIV IBES ESTIMATE OF $27.6 MILLION.Q1 EARNINGS PER SHARE ESTIMATE $-0.10 -- REFINITIV IBES DATA.SEES FY 2019 REVENUE $117 MILLION TO $121 MILLION.FY2019 REVENUE VIEW $115.0 MILLION -- REFINITIV IBES DATA.CONTINUES TO EXPECT FULL-YEAR 2019 NET CASH USED IN OPERATING ACTIVITIES TO BE IN RANGE OF $4 MILLION TO $6 MILLION.VERACYTE - CONTINUES TO EXPECT TO ACHIEVE OPERATING CASH FLOW BREAKEVEN BEFORE END OF THIS YEAR..

Veracyte Says It Receives Final Medicare Coverage Policy for Envisia Genomic Classifier

March 4 (Reuters) - Veracyte Inc <VCYT.O>::VERACYTE - RECEIVED A FINAL MEDICARE LOCAL COVERAGE DETERMINATION FOR ENVISIA GENOMIC CLASSIFIER; WILL BECOME EFFECTIVE APRIL 1, 2019.

Veracyte Sees FY 2019 Revenue Between $113 Mln To $117 Mln

Feb 25 (Reuters) - Veracyte Inc <VCYT.O>::VERACYTE ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2018 FINANCIAL RESULTS AND PROVIDES 2019 FINANCIAL OUTLOOK.SEES FY 2019 REVENUE $113 MILLION TO $117 MILLION.QTRLY REVENUE WAS $25.8 MILLION, UP 31 PERCENT.QTRLY LOSS PER SHARE $0.08.

Veracyte Reports Q3 Loss Per Share Of $0.12

Oct 29 (Reuters) - Veracyte Inc <VCYT.O>::VERACYTE ANNOUNCES THIRD QUARTER 2018 FINANCIAL RESULTS.Q3 LOSS PER SHARE $0.12.SEES FY 2018 REVENUE $90 MILLION TO $91 MILLION.Q3 REVENUE $23.5 MILLION VERSUS I/B/E/S VIEW $21.5 MILLION.Q3 EARNINGS PER SHARE VIEW $-0.25 -- THOMSON REUTERS I/B/E/S.LOWERING CASH BURN GUIDANCE FOR 2018.SEES 2018 CASH BURN $17.0 MILLION TO $18.0 MILLION.

Veracyte Announces Public Offering Of 5 Mln Shares Priced Of $10.25 Per Share

July 25 (Reuters) - Veracyte Inc <VCYT.O>::VERACYTE ANNOUNCES PRICING OF PUBLIC OFFERING OF 5,000,000 SHARES OF COMMON STOCK.PRICING OF UNDERWRITTEN PUBLIC OFFERING OF 5,000,000 SHARES OF ITS COMMON STOCK AT PUBLIC OFFERING PRICE OF $10.25 PER SHARE.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up